Infections in Invasive Pleural Procedures: A Single Centre Experience
Journal Title: International Journal of Respiratory and Pulmonary Medicine - Year 2017, Vol 4, Issue 3
Abstract
We are an established pleural centre offering medical thoracoscopy and indwelling pleural catheters. Our infection rates with prophylactic antibiotics were lower than the national average and given the era of antibiotic stewardship and lack of evidence to support the administration, we stopped giving them. We then noticed a large jump in infection rates and hence, in this paper, we reviewed our practice.
Authors and Affiliations
Keywords
Related Articles
- EP ID EP352783
- DOI 10.23937/2378-3516/1410075
- Views 122
- Downloads 0
Pulmonary Complications of Sickle Cell Disease in the Pregnant Patient
Respiratory complaints are common symptoms in pregnancy, and it is important to delineate whether the causative factor is cardiac, pulmonary, or physiologic in origin. The pathophysiology of Sickle Cell Disease (SCD) can...
The Hepatic Hydrothorax
A 74-year-old with burnt out autoimmune hepatitis, portal hypertension with thrombocytopenia, oesophageal varices and previous hepatic encephalopathy has presented with a recurrence of a left sided pleural effusion. She...
A Single Center Review of Pleural Fluid Samples
Introduction Large scale epidemiological data of pleural fluid characteristics are lacking. We are an established pleural center with high rates of pleural malignancy in the North East of England. We aim to follow the Br...
Seromucinous Hamartoma Presenting as an Obstructive Endobronchial Mass
Seromucinous hamartoma is an extremely rare entity that has been described in the sinonasal cavity and nasopharynx. We here present a case of seromucinous hamartoma manifesting as an obstructive endobronchial mass in a 6...
Antiplatelet Exposure and Bleeding Events in Patients Undergoing EBUS-TBNA
Background Periprocedural management of aspirin and clopidogrel, antiplatelet agents, for Endobronchial Ultrasound with Transbronchial Needle Aspiration (EBUS-TBNA) remains unclear. Discontinuation of antiplatelet therap...